CBInsights' latest third-quarter medical device report shows that IPO activities of major companies have entered a trough since last year. So far, there have been only 28 medical device mergers and 2 IPOs in the third quarter of 2016, and the number of IPOs has reached 8 last year. Although the IPO activities of medical device companies have slowed down, M&A activity in 2016 has reached a record high. At the same time, the scale of this year's exit is also likely to surpass last year. There is no doubt that this year will be a year of market exit.
Since 2012, the medical device industry has begun to obtain a relatively stable flow of funds. In 2016, cross-investors, mutual funds that typically focus on the public market, are increasingly active in the medical device sector, which has allowed private companies to raise $3.5 billion in financing.
For the third quarter, 28 acquisitions and 2 IPOs, we used CB Insights data to analyze the medical device industry and identified the largest medical device companies and the strongest acquirers in the industry.
Market exit behavior
In 2016, the exit of the medical equipment industry has shown an upward trend, with a year-on-year increase of 60%. Since 2012, there have been 96 first exits in the industry (including 77 acquisition exits and 19 IPOs).
As of the third quarter of 2016, the medical device company has completed 30 exits, including 28 mergers and 2 IPOs (see below).
Pulse Biosciences
Launched in May this year, formerly known as Electroblate's Pulse Biosciences, is a state-of-the-art medical device company. The company is working on an electric signal platform with a tumor treatment application. The local drug-free technology NPES is capable of inducing cellular signals using a nanosecond pulsed electric field to activate cellular pathways in tissues. The company has a market capitalization of $50 million. This new proprietary platform technology is called nanopulse electrical signal or "NPES".
Tactile Systems
In July of this year, Tactile Systems, which specializes in the development of chronic swelling treatment equipment , was launched with a market capitalization of US$166 million. Tactile Systems Technology manufactures and markets the Flexitouch Lymphedema system, which is designed to help patients control lymphedema, chronic or progressive disease through home remedies, often as a sequela of cancer treatment.
Metatron Hunter 4025
Metatron Hunter 4025,Metapathia Gr Hunter 4025,Metatron 4025 Nls,Metatron Gr Hunter 4025,Vector V16,Vector V19
The NLS Metatron Hunter 4025 machine is a bioresonance diagnostic and therapy device. It is based on the principles of quantum physics and uses the concept of resonance to assess the health status of an individual. The machine utilizes electromagnetic waves to scan the body and provide information about the functioning of various organs, tissues, and systems. It can detect imbalances, pathogens, and other factors that may contribute to health issues. The Metatron Hunter 4025 machine can also provide therapy by applying specific frequencies to restore balance and promote healing. It is used by some practitioners as a complementary tool for health assessment and treatment.
The Metapathia-GR Hunter software can operate only with the telemetric nonlinear analysis data processing apparatus "Metatron" and its subsequent modifications. The telemetric nonlinear analysis data processing device is compatible with the IBM-type PCs and intended for studying reaction of a biological object to different types of the informational impact. "Metatron" allows correlating the measurement process with the process affecting it and performs the following.
Metatron Hunter 4025,Metapathia Gr Hunter 4025,Metatron 4025 Nls,Metatron Gr Hunter 4025,Vector V16,Vector V19
Shenzhen Guangyang Zhongkang Technology Co., Ltd. , https://www.szlighttherapymachine.com